Table II.
Day | CD16+CD3- (%) | CD56+CD3- (%) | CD3+ (%) |
---|---|---|---|
0 | 0.00 | 0.00 | 0.00 |
3 | 19.6 ± 9.31 | 11.9 ± 4.78 | 1.89 ± 0.25 |
6 | 21.1 ± 9.77 | 24.5 ± 10.8 | 3.44 ± 0.23 |
9 | 27.0 ± 12.1 | 28.5 ± 6.86 | 7.50 ± 0.73 |
12 | 24.8 ± 12.0 | 25.3 ± 4.18 | 8.75 ± 0.48 |
Day | CD16+CD3- (%) | CD56+CD3- (%) | CD3+ (%) |
---|---|---|---|
0 | 0.00 | 0.00 | 0.00 |
3 | 19.6 ± 9.31 | 11.9 ± 4.78 | 1.89 ± 0.25 |
6 | 21.1 ± 9.77 | 24.5 ± 10.8 | 3.44 ± 0.23 |
9 | 27.0 ± 12.1 | 28.5 ± 6.86 | 7.50 ± 0.73 |
12 | 24.8 ± 12.0 | 25.3 ± 4.18 | 8.75 ± 0.48 |